Reduction of beta-amyloid levels by novel protein kinase C(epsilon) activators.
about
Effects of N-3 Polyunsaturated Fatty Acids on DementiaBryostatin Effects on Cognitive Function and PKCɛ in Alzheimer's Disease Phase IIa and Expanded Access Trials.Kinetics of PKCε activating and inhibiting llama single chain antibodies and their effect on PKCε translocation in HeLa cellsPolyketide β-branching in bryostatin biosynthesis: identification of surrogate acetyl-ACP donors for BryR, an HMG-ACP synthaseEffects of corticotrophin-releasing factor receptor 1 antagonists on amyloid-β and behavior in Tg2576 mice.PKC activation by resveratrol derivatives with unsaturated aliphatic chainShort- and long-term treatment of mouse cortical primary astrocytes with β-amyloid differentially regulates the mRNA expression of L-type calcium channels.PKCε promotes HuD-mediated neprilysin mRNA stability and enhances neprilysin-induced Aβ degradation in brain neuronsBryostatin-1 vs. TPPB: dose-dependent APP processing and PKC-α, -δ, and -ε isoform activation in SH-SY5Y neuronal cells.Tyrosine Binding Protein Sites Regulate the Intracellular Trafficking and Processing of Amyloid Precursor Protein through a Novel Lysosome-Directed Pathway.Corticotrophin releasing factor accelerates neuropathology and cognitive decline in a mouse model of Alzheimer's disease.Programming of neurotoxic cofactor CXCL-10 in HIV-1-associated dementia: abrogation of CXCL-10-induced neuro-glial toxicity in vitro by PKC activator.Natural products as a source of Alzheimer's drug leads.A role for the PKC signaling system in the pathophysiology and treatment of mood disorders: involvement of a functional imbalance?Are amyloid-degrading enzymes viable therapeutic targets in Alzheimer's disease?Biosynthesis of polyketides by trans-AT polyketide synthases.HepaCAM inhibits clear cell renal carcinoma 786-0 cell proliferation via blocking PKCε translocation from cytoplasm to plasma membrane.Protein kinase C-regulated aβ production and clearance.Protein Kinase Cϵ (PKCϵ) Promotes Synaptogenesis through Membrane Accumulation of the Postsynaptic Density Protein PSD-95Apolipoprotein E3 (ApoE3) but not ApoE4 protects against synaptic loss through increased expression of protein kinase C epsilon.Bryostatin-1 alleviates experimental multiple sclerosis.Inhibition of PKCδ reduces amyloid-β levels and reverses Alzheimer disease phenotypes.Sex differences in chronic stress responses and Alzheimer's disease.
P2860
Q28075307-E75AFF8B-33EF-4CFB-AFB0-78E8C1B6A05BQ33708951-9DA558B6-CDE0-4BE8-A916-E2E45C0A0359Q34247420-5B35D256-9030-4B62-81A3-586CE5F7358AQ34346093-CB097E47-C16C-407D-B6C7-E24EB5B9327CQ34517084-4056B862-F084-472A-A3B2-63C9F8EA3D03Q34534789-CE8C763F-7A78-46F2-8B75-35A522F1AA89Q35028876-B47310E1-84CA-4EAC-B2F7-E85717BF6C2EQ35172084-84D1BF29-5938-4C12-BCB6-E90A8118FB8FQ36147173-99675FEB-9295-4623-A68E-E71E87A3A9AEQ36173028-84F08434-E97B-4CEC-8829-7DA5579B5FB2Q36386509-40277BFE-C827-4BD0-94B3-3A9EF9CA95D6Q36498596-A1B29918-24FC-4806-9599-6BB2D516D5A1Q37029561-FB90480E-CE68-4AB4-B4EC-8815DB6C8483Q37943726-118F7122-973E-46E1-8D88-D98BB6F20942Q37961852-ACB5AAC7-EA7A-4523-811C-396669821B66Q38675125-FAE68BA8-3FAC-4E5D-A426-5120E5BACC1DQ39025188-AC79238A-36F3-45A6-96E2-475B1AA87537Q41869540-FD04C16B-DCED-484C-9F03-8D23A6E93621Q42037616-762E7131-67CC-44BD-B9B6-FE3B222D9973Q42084058-88CAFAEC-B97C-40E4-9AA3-270B0A49BFC6Q50026432-4973B9A7-4E41-43A9-8155-A56B2ED060E4Q54111501-4D40FF16-F31F-42BC-B157-9626A4E491B1Q55129237-C596B59D-A3C3-4316-801D-2F606CF0577E
P2860
Reduction of beta-amyloid levels by novel protein kinase C(epsilon) activators.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
2009年论文
@zh
2009年论文
@zh-cn
name
Reduction of beta-amyloid levels by novel protein kinase C
@nl
Reduction of beta-amyloid levels by novel protein kinase C(epsilon) activators.
@en
type
label
Reduction of beta-amyloid levels by novel protein kinase C
@nl
Reduction of beta-amyloid levels by novel protein kinase C(epsilon) activators.
@en
prefLabel
Reduction of beta-amyloid levels by novel protein kinase C
@nl
Reduction of beta-amyloid levels by novel protein kinase C(epsilon) activators.
@en
P2093
P2860
P356
P1476
Reduction of beta-amyloid levels by novel protein kinase C(epsilon) activators.
@en
P2093
Changhai Cui
Daniel L Alkon
Thomas J Nelson
P2860
P304
34514-34521
P356
10.1074/JBC.M109.016683
P407
P577
2009-10-22T00:00:00Z